Lipid Research Division

 View Only

JLR news via ASBMB Today: Hepatic FOXA3 inhibits obesity and steatohepatitis

  • 1.  JLR news via ASBMB Today: Hepatic FOXA3 inhibits obesity and steatohepatitis

    Posted Aug 21, 2024 04:27 PM

    A recent research study, published in the Journal of Lipid Research, by Raja Gopoju, Jiayou Wang and a team in Yanqiao Zhang's lab at NEOMED, established the positive effects of overexpressing FOXA3 on obesity and steatohepatitis in Western diet–fed mice.



    ------------------------------
    Allison Frick
    ASBMB
    ------------------------------